Gary Garfield
Pulmonary Disease · Monticello, NYNPI 1700881349
Payments from drug & device makers
Across 95 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$597
- GSK$358
- Mylan Specialty L.p.$280
- AbbVie$223
- AstraZeneca$205
- Boehringer Ingelheim$176
- plus $528 from 12 others
What the payments were for
- Food & beverage$2,35299%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $597 |
| GSK | 23 | $358 |
| Mylan Specialty L.p. | 6 | $280 |
| AbbVie(2 entities) | 7 | $223 |
| AstraZeneca | 7 | $205 |
| Boehringer Ingelheim | 11 | $176 |
| Amarin Pharma, Inc. | 7 | $116 |
| Pfizer | 7 | $115 |
| Kowa Pharmaceuticals America, Inc. | 5 | $73 |
| Dexcom, Inc. | 1 | $43 |
| Amgen | 2 | $37 |
| Novo Nordisk | 2 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novartis | 1 | $21 |
| Bayer | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Seqirus USA Inc | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,367 in reported general payments places this provider in the 60th percentile of 1,115 pulmonary disease providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Monticello
- Linda RogersNew York$7.1M
- Maria PadillaNew York$3.6M
- R WhiteRochester$3.1M
- Juan WisniveskyNew York$3M
- Bushra MinaNew York$2.5M
- Robert KanerNew York$2.3M
- Negin HajizadehGreenport$2M
- Doreen Addrizzo-HarrisNew York$1.9M
- Sherif El BayadiSyracuse$1.9M
- Daniel LachantRochester$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.